These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 34919545)
1. Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in a refugee camp, Dagahaley, Kenya. Gignoux E; Athanassiadis F; Garat Yarrow A; Jimale A; Mubuto N; Déglise C; Onsongo Mosoti D; Azman AS; Mwau M; Luquero F; Ciglenecki I PLoS One; 2021; 16(12):e0260989. PubMed ID: 34919545 [TBL] [Abstract][Full Text] [Related]
2. Seroprevalence and risk factors of SARS-CoV-2 infection in an urban informal settlement in Nairobi, Kenya, December 2020. Munywoki PK; Nasimiyu C; Alando MD; Otieno N; Ombok C; Njoroge R; Kikwai G; Odhiambo D; Osita MP; Ouma A; Odour C; Juma B; Ochieng CA; Mutisya I; Ngere I; Dawa J; Osoro E; Njenga MK; Bigogo G; Munyua P; Lo TQ; Hunsperger E; Herman-Roloff A F1000Res; 2021; 10():853. PubMed ID: 35528961 [No Abstract] [Full Text] [Related]
3. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India. Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA Front Public Health; 2022; 10():967447. PubMed ID: 36276377 [TBL] [Abstract][Full Text] [Related]
4. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic. Anand S; Montez-Rath M; Han J; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Garcia P; Dittrich M; Block GA; Parsonnet J; Chertow GM JAMA Netw Open; 2021 Jul; 4(7):e2116572. PubMed ID: 34251441 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441 [TBL] [Abstract][Full Text] [Related]
6. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic. Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813 [TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study. Álvarez-Antonio C; Meza-Sánchez G; Calampa C; Casanova W; Carey C; Alava F; Rodríguez-Ferrucci H; Quispe AM Lancet Glob Health; 2021 Jul; 9(7):e925-e931. PubMed ID: 34022148 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study. Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090 [TBL] [Abstract][Full Text] [Related]
12. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic. Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689 [TBL] [Abstract][Full Text] [Related]
13. Cholera Outbreak in Dadaab Refugee Camp, Kenya - November 2015-June 2016. Golicha Q; Shetty S; Nasiblov O; Hussein A; Wainaina E; Obonyo M; Macharia D; Musyoka RN; Abdille H; Ope M; Joseph R; Kabugi W; Kiogora J; Said M; Boru W; Galgalo T; Lowther SA; Juma B; Mugoh R; Wamola N; Onyango C; Gura Z; Widdowson MA; DeCock KM; Burton JW MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(34):958-961. PubMed ID: 30161101 [TBL] [Abstract][Full Text] [Related]
14. High levels of mortality, malnutrition, and measles, among recently-displaced Somali refugees in Dagahaley camp, Dadaab refugee camp complex, Kenya, 2011. Polonsky JA; Ronsse A; Ciglenecki I; Rull M; Porten K Confl Health; 2013 Jan; 7(1):1. PubMed ID: 23339463 [TBL] [Abstract][Full Text] [Related]
15. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?]. Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F; Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Pollán M; Pérez-Gómez B; Pastor-Barriuso R; Oteo J; Hernán MA; Pérez-Olmeda M; Sanmartín JL; Fernández-García A; Cruz I; Fernández de Larrea N; Molina M; Rodríguez-Cabrera F; Martín M; Merino-Amador P; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Yotti R; Lancet; 2020 Aug; 396(10250):535-544. PubMed ID: 32645347 [TBL] [Abstract][Full Text] [Related]
17. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study. He Z; Ren L; Yang J; Guo L; Feng L; Ma C; Wang X; Leng Z; Tong X; Zhou W; Wang G; Zhang T; Guo Y; Wu C; Wang Q; Liu M; Wang C; Jia M; Hu X; Wang Y; Zhang X; Hu R; Zhong J; Yang J; Dai J; Chen L; Zhou X; Wang J; Yang W; Wang C Lancet; 2021 Mar; 397(10279):1075-1084. PubMed ID: 33743869 [TBL] [Abstract][Full Text] [Related]
18. Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020. Bajema KL; Wiegand RE; Cuffe K; Patel SV; Iachan R; Lim T; Lee A; Moyse D; Havers FP; Harding L; Fry AM; Hall AJ; Martin K; Biel M; Deng Y; Meyer WA; Mathur M; Kyle T; Gundlapalli AV; Thornburg NJ; Petersen LR; Edens C JAMA Intern Med; 2021 Apr; 181(4):450-460. PubMed ID: 33231628 [TBL] [Abstract][Full Text] [Related]